Medication Safety
ASHP Futures 2025: What is Quiet Cracking?
Dr. Michael Wolcott defines quiet cracking and discusses how to address issues before negatively impacting the ...
JULY 17, 2026
As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists
Medicare Bridge program offers $50 copay access to GLP-1 drugs; pharmacists guide safe dosing, adherence, and side ...
JULY 14, 2026
ASHP Futures 2026: Tips for Hazardous Drug Wipe Sampling
Dr. Shannon Buxell shares her tips and best practices for effective and efficient hazardous drug wipe ...
JULY 7, 2026
ASHP Futures 2025: Medication Safety in the AI Era
Drs. Sylvia Stoffella and Ben Michaels discuss the potential of their AI pilot project to improve patient safety ...
JUNE 30, 2026
Top 10 Patient Safety Concerns of 2025: A Pharmacy-Focused Review
Patient safety 2025: Explore ECRI and ISMP’s Top 10 safety concerns and how pharmacists can lead efforts to ...
JUNE 29, 2026
ASHP Futures 2026: Proactive Tools to Modernize Medication Safety
Dr. Sondra May shares key insights from the 2026 ASHP Pharmacy Forecast and details how shifting from reactive ...
JUNE 22, 2026
ASHP Futures 2026: Recognizing Progress in Precepting
This year at ASHP Futures, Dr. Ted Morton received the ASHP Foundation 2025 Pharmacy Residency Excellence Preceptor ...
JUNE 15, 2026
Top 10 Patient Safety Concerns of 2025: A Pharmacy-Focused Review
Every clinician enters practice with a commitment to "do no harm," yet preventable harm occurs daily in healthcare ...
MAY 4, 2026
Is AI the Future of Safe Hazardous Drug Handling?
USP <800> compliance challenges and outdated NIOSH HD lists drive pharmacists to explore AI solutions for ...
APRIL 19, 2026
Is Artificial Intelligence the Future Of Safe Hazardous Drug Handling?
AI and USP <800> compliance: How pharmacists can use artificial intelligence to address outdated NIOSH ...
APRIL 2, 2026
Transforming IV Compounding Via Innovation and Integration
IV compounding modernization improves safety, efficiency, and compliance through integrated technology and ...
MARCH 20, 2026
The Polypharmacy Challenge in Tardive Dyskinesia
Movement disorders complicate patient care when multiple drugs impact dopamine and require nuanced ...
MARCH 12, 2026
